Characterisation of Cellular and Humoral Immunity in Elderly People After Immunization With a Purified, Inactivated Japanese Encephalitis Vaccine.
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2018
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- 26 Mar 2018 Status changed from recruiting to completed.
- 19 Jul 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01398540).
- 19 Jul 2011 Planned end date Jun 2012) added as reported by ClinicalTrials.gov.